| 產(chǎn)品編號(hào) | bs-2471R |
| 英文名稱 | Rabbit Anti-ICOS ligand antibody |
| 中文名稱 | 誘導(dǎo)協(xié)同刺激分子配體CD275抗體 |
| 別 名 | ICOSLG; B7 H2; B7 homolog 2; B7 homologue 2; B7 like protein Gl50; B7 related protein 1; B7-like protein Gl50; B7-related protein 1; B7-H2; B7H2; B7RP 1; B7RP-1; B7RP1; CD 275; CD275; CD275 antigen; GL 50; GL50; ICOS L; ICOS LG; ICOSL; Inducible T cell co stimulator ligand; KIAA0653; LICOS; Transmembrane protein B7 H2 ICOS ligand; ICOS ligand-like; ICOSL_HUMAN. |
 |
Specific References (1) | bs-2471R has been referenced in 1 publications.
[IF=1.26] Ma et al. Effect of follicular helper T cells on the pathogenesis of asthma. (2017) Exp.Ther.Me. 14:967-972 WB ; Mouse.
|
| 研究領(lǐng)域 | 免疫學(xué) 轉(zhuǎn)錄調(diào)節(jié)因子 細(xì)胞表面分子 |
| 抗體來(lái)源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | Human (predicted: Rat) |
| 產(chǎn)品應(yīng)用 | WB=1:500-2000,Flow-Cyt=1μg/Test
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 34kDa |
| 細(xì)胞定位 | 細(xì)胞膜 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human ICOS ligand: 19-120/302 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
ICOS ligand is a member of the B7 family and the immunoglobulin superfamily. Human ICOS ligand is expressed by activated monocytes/macrophages and dendritic cells. It binds to a CD28 like receptor, inducible costimulator molecule (ICOS, AILIM, CRP-1), which is expressed by activated T cells. This interaction plays an important role in the T cell costimulation pathway. Function: Ligand for the T-cell-specific cell surface receptor ICOS. Acts as a costimulatory signal for T-cell proliferation and cytokine secretion; induces also B-cell proliferation and differentiation into plasma cells. Could play an important role in mediating local tissue responses to inflammatory conditions, as well as in modulating the secondary immune response by co-stimulating memory T-cell function. Subunit: Membrane; Single-pass type I membrane protein. Subcellular Location: Isoform 1 is widely expressed (brain, heart, kidney, liver, lung, pancreas, placenta, skeletal muscle, bone marrow, colon, ovary, prostate, testis, lymph nodes, leukocytes, spleen, thymus and tonsil), while isoform 2 is detected only in lymph nodes, leukocytes and spleen. Expressed on activated monocytes and dendritic cells. Similarity: Belongs to the immunoglobulin superfamily. BTN/MOG family. Contains 1 Ig-like C2-type (immunoglobulin-like) domain. Contains 1 Ig-like V-type (immunoglobulin-like) domain. SWISS: O75144 Gene ID: 23308 Database links: Entrez Gene: 23308 Human Entrez Gene: 50723 Mouse Omim: 605717 Human SwissProt: O75144 Human SwissProt: Q9JHJ8 Mouse Unigene: 14155 Human Unigene: 17819 Mouse
B7協(xié)同刺激分子及其相應(yīng)受體結(jié)合所產(chǎn)生的信號(hào)在調(diào)節(jié)T細(xì)胞活化及效應(yīng)性細(xì)胞因子分泌中起重要作用，具有負(fù)性調(diào)節(jié)作用的協(xié)同刺激分子對(duì)免疫應(yīng)答的適度進(jìn)行、防止自身免疫疾病的發(fā)生具有重要作用。 B7H2可協(xié)同刺激CD14 + 細(xì)胞增殖，并分泌IL-4、IL-5、IFN-β、TNF-α、GM-CSF和IL-10等細(xì)胞因子，但不能協(xié)同刺激T細(xì)胞上調(diào)IL-2的分泌。 |
| 產(chǎn)品圖片 |
Sample:
Lane 1: Human Daudi cell lysates
Lane 2: Human HL-60 cell lysates
Lane 3: Human JAR cell lysates
Primary: Anti-ICOS ligand (bs-2471R) at 1/1000 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 34 kDa
Observed band size: 60 kDa
Blank controlBlue):Jurkat cells (fixed with 2% paraformaldehyde (10 min)). Primary Antibody:Rabbit Anti-ICOS ligand antibody(bs-2471R), Dilution: 1μg in 100 μL 1X PBS containing 0.5% BSA;
Isotype Control Antibody: Rabbit IgG(orange),used under the same conditions );
Secondary Antibody: Goat anti-rabbit IgG-PE(white blue), Dilution: 1:200 in 1 X PBS containing 0.5% BSA.
Protocol
The cells were fixed with 2% paraformaldehyde (10 min). Primary antibody (bs-2471R, 1μg /1x10^6 cells) were incubated for 30 min on the ice, followed by 1 X PBS containing 0.5% BSA + 1 0% goat serum (15 min) to block non-specific protein-protein interactions. Then the Goat Anti-rabbit IgG/PE antibody was added into the blocking buffer mentioned above to react with the primary antibody at 1/200 dilution for 30 min on ice. Acquisition of 20,000 events was performed.
|
